En vivo
CellB cell deficiency limits exercise capacity by remodeling liver glutamate metabolismCellA phytoscreen identifies a garlic compound as a deterrent of mating and egg laying in <em>Drosophila</em> and mosquitoesCellp53 safeguards chemical reprogramming of human somatic cells toward pluripotencyCell2'3'-cGAMP-induced membrane shearing promotes broad antiphage immunityCellGut microbiome is associated with recurrence-free survival in patients with resected high-risk melanoma receiving adjuvant immune checkpoint blockadeFierceBiotechAACR: Endeavoring to go global, Zai Lab offers reality check on China’s biotech ascentNVIDIAGoogle developing inference AI chips to rival Nvidia - qz.comCorningSpring book sale returns to benefit Southeast Steuben County Library - WETMBioPharma DiveRFK Jr. defends HHS tenure, 12% proposed budget cutInsilico MedicineInsilico Medicine Highlights AI Benchmarking Platform for Drug Discovery - TipRanksBDBD Wong to Star in Solo Performance of The Glass Menagerie for Philadelphia Theatre Company - TheaterManiaIlluminaTsinghua University brings hands-on multiomics training to young scientists - Illumina
Endpoints News 14 abr 2026

FDA approves Travere's Filspari as first drug for the kidney disease FSGS

FDA approves Travere's Filspari as first drug for the kidney disease FSGS

Original
Contenido no disponible. Consulta la fuente original.